A420570 Stock Overview
A bio venture company, provides active ingredients for cosmetics, functional food, and household products from natural materials and microbial fermentation.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
J2KBIO Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩32,300.00 |
| 52 Week High | ₩41,250.00 |
| 52 Week Low | ₩11,810.00 |
| Beta | 0 |
| 1 Month Change | 80.95% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 24.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| A420570 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 35.1% | -2.2% | -1.7% |
| 1Y | n/a | -0.4% | 0.6% |
Return vs Industry: Insufficient data to determine how A420570 performed against the KR Biotechs industry.
Return vs Market: Insufficient data to determine how A420570 performed against the KR Market.
Price Volatility
| A420570 volatility | |
|---|---|
| A420570 Average Weekly Movement | 22.3% |
| Biotechs Industry Average Movement | 8.2% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in KR Market | 11.3% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A420570's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine A420570's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Jaeseop Lee | www.j2kbio.com |
J2KBIO Co., Ltd., a bio venture company, provides active ingredients for cosmetics, functional food, and household products from natural materials and microbial fermentation. The company was founded in 2014 and is based in Cheongju, South Korea.
J2KBIO Co., Ltd. Fundamentals Summary
| A420570 fundamental statistics | |
|---|---|
| Market cap | ₩179.43b |
| Earnings (TTM) | -₩330.74m |
| Revenue (TTM) | ₩30.85b |
5.8x
P/S Ratio-542.5x
P/E RatioIs A420570 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A420570 income statement (TTM) | |
|---|---|
| Revenue | ₩30.85b |
| Cost of Revenue | ₩18.44b |
| Gross Profit | ₩12.41b |
| Other Expenses | ₩12.74b |
| Earnings | -₩330.74m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -59.54 |
| Gross Margin | 40.23% |
| Net Profit Margin | -1.07% |
| Debt/Equity Ratio | 10.4% |
How did A420570 perform over the long term?
See historical performance and comparison